First hearing research paper describes rationale and design of low-dose aspirin and hearing progression Loss of hearing can have a profound effect on a person’s independence and quality of life. Up to two-thirds of people over the age of 70 years will experience hearing loss associated with ageing and there is no known single cause and no known cure.…
Details
Late last month saw the launch of an aspirin study called ADD-Aspirin to investigate whether aspirin can be used to prevent or delay the recurrence of a cancer. People living in India and the UK who have had, or are undergoing early treatment for cancer in the oesophagus, stomach, bowel or breast or prostate are eligible to participate. Funded…
Details
Australia’s iconic Parliament House formed the backdrop for the latest Biobank team adventure. In late August, our team spent the week on a round trip from Melbourne up to Cooma, Goulburn and Canberra, collecting 3 year follow-up samples destined for the ASPREE Healthy Ageing Biobank and DEPM Biorepository. We thank our intrepid travellers for their good work and the…
Details
Service Engineer, Ian Whittle spent the day re-calibrating eight audiometers in preparation for repeat hearing tests that are about to be undertaken by participants in the ASPREE-Hearing sub-study. More than 1200 ASPREE-Hearing participants had a hearing test upon enrolment into the Hearing sub-study. Many are due for repeat 18 month hearing tests starting from this month. In regional and rural…
Details
Researchers await verification of aspirin and cancer survival announcement A report that aspirin doubled the life expectancy of patients with gastrointestinal cancer should be viewed with caution until there is proof to substantiate the claim, said Australian oncologist and cancer researcher, Associate Professor Peter Gibbs. The European Cancer Congress in Vienna recently announced a Netherlands…
Details
The President of Golden Days FM, Melbourne’s Senior Broadcast radio, recently spoke to Professor Andrew Tonkin, a senior investigator to the ASPREE trial on the progress of the study. Prof. Tonkin, Head of the Cardiovascular Research Unit at Monash University, oversees cardiovascular aspects of ASPREE. Our thanks to Larry James for the opportunity to discuss the study with listeners…
Details
We are delighted to have Australian of the Year, Ita Buttrose, feature in two ASPREE Community Service Announcements (CSAs). The short 30 second and 15 second videos thank ASPREE participants for their extraordinary contribution to the health of future generations. Both CSAs are currently being aired on TVs across south eastern Australia. The radio CSA can be…
DetailsLeading US health authority releases aspirin recommendations to prevent cardiovascular disease and cancer in middle-aged The US Preventive Services Task Force (USPSTF) yesterday proposed that aspirin should be taken by more people to prevent cardiovascular disease (heart attack and stroke) as well as colon cancer – but only if you are aged between 50 and…
Details
Representatives from Museum Victoria recently visited the new Monash University DEPM Biorepository to learn about the inner workings of the state-of-the-art long term storage facility. Dr Joanna Sumner (pictured), Manager of Genetic Resources at Museum Victoria took a hands-on approach, examining the tanks, storage racks and other design considerations with colleagues Christine Tipton, Business and…
Details
We are so fortunate to have a terrific Biobank research team with a yen for travel and good food. Led by Tom Gilbert, the team of ten has clocked up hundreds of hours flying or driving around south eastern Australia, to collect and process samples for the Healthy Ageing Biobank. In addition to their important research work,…
Details© 2019 All Rights Reserved. • Monash University, Department of Epidemiology and Preventive Medicine | Disclaimer & Privacy